BDX logo Becton, Dickinson and Company +
Becton, Dickinson and Company
+
Revenue breakdown by Products & Services
Revenue breakdown by Geography

Becton, Dickinson and Company's Revenue by Segment

In fiscal year 2025, Becton, Dickinson and Company's revenue by segment (products & services) are as follows:

  • Interventional: $5.22 B
  • Life Sciences: $5.17 B
  • Medical: $11.46 B

Learn more about Becton, Dickinson and Company’s Revenue by Geography

Check out competitors to Becton, Dickinson and Company in a side-by-side comparison.

Explore additional financial metrics for Becton, Dickinson and Company.

Continue reading...

The above chart shows Becton, Dickinson and Company's revenue percentage share by segment (products and services).

In fiscal year 2023, Becton, Dickinson and Company's revenue by segment is as follows:

  • Interventional generated $4.74 B in revenue, representing 24.45% of its total revenue.
  • Life Sciences generated $5.13 B in revenue, representing 26.5% of its total revenue.
  • Medical generated $9.50 B in revenue, representing 49.05% of its total revenue.

The biggest segment for Becton, Dickinson and Company is the Medical, which represents 49.05% of its total revenue.
The smallest segment for Becton, Dickinson and Company is the Interventional, which represents 24.45% of its total revenue.

The above chart shows Becton, Dickinson and Company's revenue percentage share by segment (products and services).

In fiscal year 2024, Becton, Dickinson and Company's revenue by segment is as follows:

  • Interventional generated $4.98 B in revenue, representing 24.6% of its total revenue.
  • Life Sciences generated $5.19 B in revenue, representing 25.64% of its total revenue.
  • Medical generated $10.07 B in revenue, representing 49.76% of its total revenue.

The biggest segment for Becton, Dickinson and Company is the Medical, which represents 49.76% of its total revenue.
The smallest segment for Becton, Dickinson and Company is the Interventional, which represents 24.6% of its total revenue.

The above chart shows Becton, Dickinson and Company's revenue percentage share by segment (products and services).

In fiscal year 2025, Becton, Dickinson and Company's revenue by segment is as follows:

  • Interventional generated $5.22 B in revenue, representing 23.89% of its total revenue.
  • Life Sciences generated $5.17 B in revenue, representing 23.66% of its total revenue.
  • Medical generated $11.46 B in revenue, representing 52.45% of its total revenue.

The biggest segment for Becton, Dickinson and Company is the Medical, which represents 52.45% of its total revenue.
The smallest segment for Becton, Dickinson and Company is the Life Sciences, which represents 23.66% of its total revenue.
Continue reading...

Summary Table

Products & Services (Percent Share) 2023 2024 2025
Life Sciences 26.5% 25.64% 23.66%
Medical 49.05% 49.76% 52.45%
Interventional 24.45% 24.6% 23.89%
Total Revenue 100% 100% 100%

The above chart shows the revenue trend of different segments of Becton, Dickinson and Company.

In fiscal year 2025, the Medical generated the most revenue ($11.46 B), and the Life Sciences generated the least revenue ($5.17 B).

The above chart shows growth drivers and a year-over-year comparison of different segments' revenue.

  • Interventional revenue increased 4.76% ($237.00 M) from $4.98 B (in 2024) to $5.22 B (in 2025).
  • Life Sciences revenue decreased -0.46% ($24.00 M) from $5.19 B (in 2024) to $5.17 B (in 2025).
  • Medical revenue increased 13.72% ($1.38 B) from $10.07 B (in 2024) to $11.46 B (in 2025).
    • Continue reading...

    Summary Table

    Products & Services 2023
    Value Change
    		2024
    Value Change
    		2025
    Value Change
    Interventional $4.74 B - $4.98 B
    5.15%
    		$5.22 B
    4.76%
    Life Sciences $5.13 B - $5.19 B
    1.13%
    		$5.17 B
    0.46%
    Medical $9.50 B - $10.07 B
    6.02%
    		$11.46 B
    13.72%
    Total Revenue $19.37 B - $20.18 B
    4.16%
    		$21.84 B
    8.23%

    Frequently Asked Questions

    What was Becton, Dickinson and Company's largest product segment last year?

    In fiscal year 2025, Medical revenue reached $11.46 Billion, representing 52.45% of Becton, Dickinson and Company's total revenue and making it the largest segment for the company.

    Which product segment experienced the highest growth for Becton, Dickinson and Company last year?

    The Medical segment is Becton, Dickinson and Company's highest growth segment, with a revenue growth of +13.72% in 2025 compared to 2024.

    Related company

    Submit feedback to Bullfincher